Search results
We’re on the road with a new approach to clinical trials—one that expands access to cutting-edge medicines and treatments. Lilly is a medicine company turning science into healing to make life better for people around the world.
Lilly unites caring with discovery to create medicines that make life better for people around the world.
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
Since its inception in India in 1993, Eli Lilly and Company (India) Pvt. Ltd. has been committed to developing and marketing pharmaceutical products to treat diabetes, gastric cancer, lung cancer, breast cancer, osteoporosis, rheumatoid arthritis, men's health and growth-hormone deficiency.
Jun 24, 2024 · The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.
3 days ago · Lilly intends to donate Kisunla to the Lilly Cares Foundation, a separate nonprofit organization that makes medicines available at no cost to qualified Americans, including some Medicare beneficiaries, who meet financial eligibility and other criteria. This is consistent with Lilly's long history of supporting access to our products to patients with financial need through medication donations to charitable organizations.
2 days ago · Lilly said it will be sold under the name Kisunla and would cost $695 per vial before insurance, what would amount to $12,522 for a six-month course or about $32,000 for a year, depending on when ...
3 days ago · The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.
2 days ago · Updated on. July 2, 2024 at 1:08 PM PDT. Eli Lilly & Co. ’s Alzheimer’s treatment was cleared in the US as the second drug to slow progression of the mind-robbing disease that afflicts 6 ...
2 days ago · Lilly's drug has another potential advantage: Patients can stop taking it if they respond well. In the company's study, patients were taken off Kisunla once their brain plaque reached low levels ...
